Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 142

1.

Enhancing oxygen delivery to ovarian follicles by three different methods markedly improves growth in serum-containing culture medium.

Connolly JM, Kane MT, Quinlan LR, Hynes AC.

Reprod Fertil Dev. 2019 Apr 12. doi: 10.1071/RD18286. [Epub ahead of print]

PMID:
30975286
2.

Racial Inequities in Drug Arrests: Treatment in Lieu of and After Incarceration.

Ferrer B, Connolly JM.

Am J Public Health. 2018 Aug;108(8):968-969. doi: 10.2105/AJPH.2018.304575. No abstract available.

3.

Corrigendum to: Hypoxia limits mouse follicle growth in vitro.

Connolly JM, Kane MT, Quinlan LR, Dockery P, Hynes AC.

Reprod Fertil Dev. 2017 Feb;29(2):431. doi: 10.1071/RD14471_CO.

PMID:
29145927
4.

Non-invasive and label-free detection of oral squamous cell carcinoma using saliva surface-enhanced Raman spectroscopy and multivariate analysis.

Connolly JM, Davies K, Kazakeviciute A, Wheatley AM, Dockery P, Keogh I, Olivo M.

Nanomedicine. 2016 Aug;12(6):1593-601. doi: 10.1016/j.nano.2016.02.021. Epub 2016 Mar 23.

PMID:
27015768
5.

Estimation of a biofilm-specific reaction rate: kinetics of bacterial urea hydrolysis in a biofilm.

Connolly JM, Jackson B, Rothman AP, Klapper I, Gerlach R.

NPJ Biofilms Microbiomes. 2015 Sep 16;1:15014. doi: 10.1038/npjbiofilms.2015.14. eCollection 2015.

6.

Point of care optical diagnostic technologies for the detection of oral and oropharyngeal squamous cell carcinoma.

Davies K, Connolly JM, Dockery P, Wheatley AM, Olivo M, Keogh I.

Surgeon. 2015 Dec;13(6):321-9. doi: 10.1016/j.surge.2015.06.004. Epub 2015 Jul 3. Review.

PMID:
26148762
7.

Hypoxia limits mouse follicle growth in vitro.

Connolly JM, Kane MT, Quinlan LR, Dockery P, Hynes AC.

Reprod Fertil Dev. 2015 Apr 13. doi: 10.1071/RD14471. [Epub ahead of print]

PMID:
25863967
8.
9.

The craving experience questionnaire: a brief, theory-based measure of consummatory desire and craving.

May J, Andrade J, Kavanagh DJ, Feeney GF, Gullo MJ, Statham DJ, Skorka-Brown J, Connolly JM, Cassimatis M, Young RM, Connor JP.

Addiction. 2014 May;109(5):728-35. doi: 10.1111/add.12472. Epub 2014 Feb 16.

PMID:
24400950
10.

The susceptibility of bioprosthetic heart valve leaflets to oxidation.

Christian AJ, Lin H, Alferiev IS, Connolly JM, Ferrari G, Hazen SL, Ischiropoulos H, Levy RJ.

Biomaterials. 2014 Feb;35(7):2097-102. doi: 10.1016/j.biomaterials.2013.11.045. Epub 2013 Dec 18.

11.

Taxis toward hydrogen gas by Methanococcus maripaludis.

Brileya KA, Connolly JM, Downey C, Gerlach R, Fields MW.

Sci Rep. 2013 Nov 5;3:3140. doi: 10.1038/srep03140. Erratum in: Sci Rep. 2014;4:3690.

12.

Coreceptor affinity for MHC defines peptide specificity requirements for TCR interaction with coagonist peptide-MHC.

Hoerter JA, Brzostek J, Artyomov MN, Abel SM, Casas J, Rybakin V, Ampudia J, Lotz C, Connolly JM, Chakraborty AK, Gould KG, Gascoigne NR.

J Exp Med. 2013 Aug 26;210(9):1807-21. doi: 10.1084/jem.20122528. Epub 2013 Aug 12.

13.

Adenoviral vector tethering to metal surfaces via hydrolyzable cross-linkers for the modulation of vector release and transduction.

Fishbein I, Forbes SP, Chorny M, Connolly JM, Adamo RF, Corrales RA, Alferiev IS, Levy RJ.

Biomaterials. 2013 Sep;34(28):6938-48. doi: 10.1016/j.biomaterials.2013.05.047. Epub 2013 Jun 15.

14.

Craving as a predictor of treatment outcomes in heavy drinkers with comorbid depressed mood.

Connolly JM, Kavanagh DJ, Baker AL, Kay-Lambkin FJ, Lewin TJ, Davis PJ, Quek LH.

Addict Behav. 2013 Feb;38(2):1585-92. doi: 10.1016/j.addbeh.2012.06.003. Epub 2012 Jun 9.

PMID:
22727783
15.

T cell receptor signaling is limited by docking geometry to peptide-major histocompatibility complex.

Adams JJ, Narayanan S, Liu B, Birnbaum ME, Kruse AC, Bowerman NA, Chen W, Levin AM, Connolly JM, Zhu C, Kranz DM, Garcia KC.

Immunity. 2011 Nov 23;35(5):681-93. doi: 10.1016/j.immuni.2011.09.013.

16.

Triglycidyl amine crosslinking combined with ethanol inhibits bioprosthetic heart valve calcification.

Connolly JM, Bakay MA, Alferiev IS, Gorman RC, Gorman JH 3rd, Kruth HS, Ashworth PE, Kutty JK, Schoen FJ, Bianco RW, Levy RJ.

Ann Thorac Surg. 2011 Sep;92(3):858-65. doi: 10.1016/j.athoracsur.2011.04.104.

17.

Aortic valve cyclic stretch causes increased remodeling activity and enhanced serotonin receptor responsiveness.

Balachandran K, Bakay MA, Connolly JM, Zhang X, Yoganathan AP, Levy RJ.

Ann Thorac Surg. 2011 Jul;92(1):147-53. doi: 10.1016/j.athoracsur.2011.03.084.

18.

The effect of CD47 modified polymer surfaces on inflammatory cell attachment and activation.

Stachelek SJ, Finley MJ, Alferiev IS, Wang F, Tsai RK, Eckells EC, Tomczyk N, Connolly JM, Discher DE, Eckmann DM, Levy RJ.

Biomaterials. 2011 Jul;32(19):4317-26. doi: 10.1016/j.biomaterials.2011.02.053. Epub 2011 Mar 22.

19.

Americans' conflicting views about the public health system, and how to shore up support.

Blendon RJ, Benson JM, SteelFisher GK, Connolly JM.

Health Aff (Millwood). 2010 Nov;29(11):2033-40. doi: 10.1377/hlthaff.2010.0262.

PMID:
21041745
20.

Basic and translational applications of engineered MHC class I proteins.

Hansen TH, Connolly JM, Gould KG, Fremont DH.

Trends Immunol. 2010 Oct;31(10):363-9. doi: 10.1016/j.it.2010.07.003. Epub 2010 Sep 9. Review.

21.

A single peptide-MHC complex positively selects a diverse and specific CD8 T cell repertoire.

Wang B, Primeau TM, Myers N, Rohrs HW, Gross ML, Lybarger L, Hansen TH, Connolly JM.

Science. 2009 Nov 6;326(5954):871-4. doi: 10.1126/science.1177627.

22.

Physicians' views of the Massachusetts Health Care Reform Law--a poll.

Steelfisher GK, Blendon RJ, Sussman T, Connolly JM, Benson JM, Herrmann MJ.

N Engl J Med. 2009 Nov 5;361(19):e39. doi: 10.1056/NEJMp0909851. Epub 2009 Oct 21. No abstract available.

PMID:
19846839
23.

Serum serotonin concentrations in dogs with degenerative mitral valve disease.

Arndt JW, Reynolds CA, Singletary GE, Connolly JM, Levy RJ, Oyama MA.

J Vet Intern Med. 2009 Nov-Dec;23(6):1208-13. doi: 10.1111/j.1939-1676.2009.0378.x. Epub 2009 Aug 26.

24.

Fenfluramine disrupts the mitral valve interstitial cell response to serotonin.

Connolly JM, Bakay MA, Fulmer JT, Gorman RC, Gorman JH 3rd, Oyama MA, Levy RJ.

Am J Pathol. 2009 Sep;175(3):988-97. doi: 10.2353/ajpath.2009.081101. Epub 2009 Aug 13.

25.

Biomechanical and biologic effects of meniscus stabilization using triglycidyl amine.

Hunter SA, Rapoport HS, Connolly JM, Alferiev I, Fulmer J, Murti BH, Herfat M, Noyes FR, Butler DL, Levy RJ.

J Biomed Mater Res A. 2010 Apr;93(1):235-42. doi: 10.1002/jbm.a.32523.

PMID:
19557790
26.

Interventions for co-occurring addictive and other mental disorders (AMDs).

Kavanagh DJ, Connolly JM.

Addict Behav. 2009 Oct;34(10):838-45. doi: 10.1016/j.addbeh.2009.03.005. Epub 2009 Mar 9.

PMID:
19345511
27.

Mailed treatment to augment primary care for alcohol disorders: a randomised controlled trial.

Kavanagh D, Connolly JM.

Drug Alcohol Rev. 2009 Jan;28(1):73-80. doi: 10.1111/j.1465-3362.2008.00011.x.

PMID:
19320679
28.

Human major histocompatibility complex (MHC) class I molecules with disulfide traps secure disease-related antigenic peptides and exclude competitor peptides.

Truscott SM, Wang X, Lybarger L, Biddison WE, McBerry C, Martinko JM, Connolly JM, Linette GP, Fremont DH, Hansen TH, Carreno BM.

J Biol Chem. 2008 Mar 21;283(12):7480-90. doi: 10.1074/jbc.M709935200. Epub 2008 Jan 14.

29.

In vivo biomechanical assessment of triglycidylamine crosslinked pericardium.

Sacks MS, Hamamoto H, Connolly JM, Gorman RC, Gorman JH 3rd, Levy RJ.

Biomaterials. 2007 Dec;28(35):5390-8. Epub 2007 Sep 5.

30.

Structural engineering of pMHC reagents for T cell vaccines and diagnostics.

Mitaksov V, Truscott SM, Lybarger L, Connolly JM, Hansen TH, Fremont DH.

Chem Biol. 2007 Aug;14(8):909-22.

31.

Disulfide bond engineering to trap peptides in the MHC class I binding groove.

Truscott SM, Lybarger L, Martinko JM, Mitaksov VE, Kranz DM, Connolly JM, Fremont DH, Hansen TH.

J Immunol. 2007 May 15;178(10):6280-9.

32.

Transforming growth factor-beta1 mechanisms in aortic valve calcification: increased alkaline phosphatase and related events.

Clark-Greuel JN, Connolly JM, Sorichillo E, Narula NR, Rapoport HS, Mohler ER 3rd, Gorman JH 3rd, Gorman RC, Levy RJ.

Ann Thorac Surg. 2007 Mar;83(3):946-53.

PMID:
17307438
33.

Mechanisms of the in vivo inhibition of calcification of bioprosthetic porcine aortic valve cusps and aortic wall with triglycidylamine/mercapto bisphosphonate.

Rapoport HS, Connolly JM, Fulmer J, Dai N, Murti BH, Gorman RC, Gorman JH, Alferiev I, Levy RJ.

Biomaterials. 2007 Feb;28(4):690-9. Epub 2006 Oct 6.

34.

Surface heparinization of polyurethane via bromoalkylation of hard segment nitrogens.

Alferiev IS, Connolly JM, Stachelek SJ, Ottey A, Rauova L, Levy RJ.

Biomacromolecules. 2006 Jan;7(1):317-22.

PMID:
16398531
35.

Cholesterol-modified polyurethane valve cusps demonstrate blood outgrowth endothelial cell adhesion post-seeding in vitro and in vivo.

Stachelek SJ, Alferiev I, Connolly JM, Sacks M, Hebbel RP, Bianco R, Levy RJ.

Ann Thorac Surg. 2006 Jan;81(1):47-55.

PMID:
16368333
36.

Site specific gene delivery in the cardiovascular system.

Fishbein I, Stachelek SJ, Connolly JM, Wilensky RL, Alferiev I, Levy RJ.

J Control Release. 2005 Dec 5;109(1-3):37-48. Epub 2005 Nov 17. Review.

PMID:
16298010
37.

Applications of major histocompatibility complex class I molecules expressed as single chains.

Primeau T, Myers NB, Yu YY, Lybarger L, Wang X, Truscott SM, Hansen TH, Connolly JM.

Immunol Res. 2005;32(1-3):109-21. Review.

PMID:
16106063
38.

Posttranslational control of a cardiac ion channel transgene in vivo: clarithromycin-hMiRP1-Q9E interactions.

Perlstein I, Burton DY, Ryan K, Defelice S, Simmers E, Campbell B, Connolly JM, Hoffman A, Levy RJ.

Hum Gene Ther. 2005 Jul;16(7):906-10.

PMID:
16000071
39.

Triglycidylamine crosslinking of porcine aortic valve cusps or bovine pericardium results in improved biocompatibility, biomechanics, and calcification resistance: chemical and biological mechanisms.

Connolly JM, Alferiev I, Clark-Gruel JN, Eidelman N, Sacks M, Palmatory E, Kronsteiner A, Defelice S, Xu J, Ohri R, Narula N, Vyavahare N, Levy RJ.

Am J Pathol. 2005 Jan;166(1):1-13.

40.

Transcription factor Egr-1 in calcific aortic valve disease.

Ghazvini-Boroujerdi M, Clark J, Narula N, Palmatory E, Connolly JM, DeFelice S, Xu J, Jian B, Hazelwood S, Levy RJ.

J Heart Valve Dis. 2004 Nov;13(6):894-903.

PMID:
15597579
41.

Ethanol inhibition of porcine bioprosthetic heart valve cusp calcification is enhanced by reduction with sodium borohydride.

Connolly JM, Alferiev I, Kronsteiner A, Lu Z, Levy RJ.

J Heart Valve Dis. 2004 May;13(3):487-93.

PMID:
15222297
42.

The development of preferences for specific body shapes.

Connolly JM, Slaughter V, Mealey L.

J Sex Res. 2004 Feb;41(1):5-15.

PMID:
15216420
43.

Localized gene delivery using antibody tethered adenovirus from polyurethane heart valve cusps and intra-aortic implants.

Stachelek SJ, Song C, Alferiev I, Defelice S, Cui X, Connolly JM, Bianco RW, Levy RJ.

Gene Ther. 2004 Jan;11(1):15-24.

PMID:
14681693
44.

DNA delivery from an intravascular stent with a denatured collagen-polylactic-polyglycolic acid-controlled release coating: mechanisms of enhanced transfection.

Perlstein I, Connolly JM, Cui X, Song C, Li Q, Jones PL, Lu Z, DeFelice S, Klugherz B, Wilensky R, Levy RJ.

Gene Ther. 2003 Aug;10(17):1420-8.

PMID:
12900756
45.

Prevention of polyurethane valve cusp calcification with covalently attached bisphosphonate diethylamino moieties.

Alferiev I, Stachelek SJ, Lu Z, Fu AL, Sellaro TL, Connolly JM, Bianco RW, Sacks MS, Levy RJ.

J Biomed Mater Res A. 2003 Aug 1;66(2):385-95.

PMID:
12889009
46.

The incorporation of an ion channel gene mutation associated with the long QT syndrome (Q9E-hMiRP1) in a plasmid vector for site-specific arrhythmia gene therapy: in vitro and in vivo feasibility studies.

Burton DY, Song C, Fishbein I, Hazelwood S, Li Q, DeFelice S, Connolly JM, Perlstein I, Coulter DA, Levy RJ.

Hum Gene Ther. 2003 Jun 10;14(9):907-22.

PMID:
12828861
47.

Enhanced immune presentation of a single-chain major histocompatibility complex class I molecule engineered to optimize linkage of a C-terminally extended peptide.

Lybarger L, Yu YY, Miley MJ, Fremont DH, Myers N, Primeau T, Truscott SM, Connolly JM, Hansen TH.

J Biol Chem. 2003 Jul 18;278(29):27105-11. Epub 2003 May 5.

48.
49.
50.

Peptide length variants p2Ca and QL9 present distinct conformations to L(d)-specific T cells.

Hornell TM, Martin SM, Myers NB, Connolly JM.

J Immunol. 2001 Oct 15;167(8):4207-14.

Supplemental Content

Loading ...
Support Center